Immediate Impact
6 from Science/Nature 57 standout
Citing Papers
Secondary Cancers after Chimeric Antigen Receptor T-Cell Therapy
2024 Standout
Interstitial Lung Disease
2024 Standout
Works of Keiko Ueda being referenced
Safety and efficacy of rituximab in systemic sclerosis (DESIRES): a double-blind, investigator-initiated, randomised, placebo-controlled trial
2021 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Keiko Ueda | 237 | 171 | 206 | 301 | 288 | 59 | 1.2k | |
| Günter Stein | 124 | 92 | 208 | 496 | 306 | 66 | 1.7k | |
| Kai Lau | 249 | 231 | 205 | 180 | 594 | 46 | 1.6k | |
| Neil Dalton | 215 | 75 | 273 | 231 | 262 | 53 | 1.3k | |
| Michaele B. Manigrasso | 175 | 252 | 184 | 287 | 426 | 33 | 1.7k | |
| Mika Enomoto | 127 | 265 | 349 | 226 | 194 | 54 | 1.4k | |
| Jacques Bernheim | 258 | 105 | 210 | 109 | 200 | 60 | 1.4k | |
| Alev Hasanoğlu | 83 | 144 | 314 | 170 | 240 | 88 | 1.2k | |
| Takuhito Shoji | 85 | 225 | 198 | 549 | 206 | 39 | 1.4k | |
| Dariusz Moczulski | 49 | 133 | 210 | 155 | 280 | 65 | 1.4k | |
| Necat Yılmaz | 60 | 88 | 149 | 150 | 231 | 83 | 1.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...